- No categories
- Artemisinin derivatives
- CEO
- Contact us
- Contract research
- Custom synthesis
- Fluorescent labeling of small molecules
- Hit finding, assay development & screening
- Hit-to-lead optimization, patentable lead generation
- Home
- Liquid handling & sample management
- Magyarország megújul
- Ongoing and earlier projects
- Partners
- Patents invented by our scientists
- PI3K-AKT-mTOR pathway inhibitors
- Process development & optimization
- R&D projects
- Scientific advisory board
- Services
- Site Map
- Strategic alliances
- Synthetic chemistry services for target identification
- Top publications
- Új tuberkulózis ellenes gyógyszerek fejlesztése indult a Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal támogatásával (TÉT_13_DST-1-2013-0012)
- Vichem pipeline
- Vision & Mission
- Nested Chemical Library™ (NCL)
- DriverHit Library® (DHL)
- HIV
- Allosteric Library (AL)
- Development of selective FLT3 inhibitors
- FGFR inhibitors
- Tool Compound Libary (TCL)
- Kinase inhibitor building blocks